Synageva Team

Our team was assembled to effectively advance multiple rare disease programs from the lab through late-stage clinical and commercial development. Our in-house expertise is uniquely qualified to leverage the core competitive advantages of our platform in the rare disease space. Synageva's management team has broad industry experience, a track record of success across all phases of product development and commercialization, and has collectively played pivotal roles in developing and/or commercializing the majority of the enzyme replacement therapies that have been brought to market to date.